Stability Indicating RP-HPLC Method Development and Validation for Simultaneous Quantification of 15 Organic Impurities of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in Combined Dosage Form

被引:0
作者
Pritesh R. Desai
Priti J. Mehta
Avani B. Chokshi
机构
[1] Zydus Cadila Healthcare Limited,Department of Analytical Research
[2] Nirma University,Institute of Phamacy
[3] CHARUSAT,Ramanbhai Patel College of Pharmacy
来源
Chromatographia | 2019年 / 82卷
关键词
High-performance liquid chromatography; Impurity; Method validation; Olmesartan medoxomil; Amlodipine besylate; Hydrochlorothiazide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:819 / 833
页数:14
相关论文
共 136 条
[1]  
Brousil JA(2003)Olmesartan medoxomil: an angiotensin II-receptor blocker Clin Ther 25 1041-1055
[2]  
Burke JM(1997)Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients J Hypertens 15 1809-1812
[3]  
Püchler K(2005)The extra pharmacopoeia The Complete Drug Reference 34 2005-2163
[4]  
Nussberger J(2003)Novel vascular biology of third-generation Arter Thromb Vasc Biol 23 2155-102
[5]  
Laeis P(2002)-type calcium channel antagonists: ancillary actions of amlodipine J Hypertens 20 95-349
[6]  
Witte PU(1959)Dual mechanism of action of amlodipine in human vascular smooth muscle cells Toxicol Appl Pharmacol 1 333-1685
[7]  
Brunner HR(1998)The pharmacology of hydrochlorothiazide (Esidrix™), a new, orally effective sulfonamide diuretic Nephrol Dial Transplant 13 1682-298
[8]  
Martindale KP(2012)The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide Curr Cardiovasc Risk Rep 6 291-422
[9]  
Mason RP(2007)Combination therapy in hypertension Pharmazie 62 419-133
[10]  
Marche P(1997)Determination of olmesartan medoxomil in tablets by UV–Vis spectrophotometry Anal Lett 30 121-146